Immune checkpoint inhibitors (ICIs) are agents which function through impeding immune evasion mechanisms exhibited by various cancers, and programmed cell death 1 (PD-1) and its ligand (PD-L1) blockers are representative ICIs. The gene discussed is PDCD1; the disease is cancer.